MG2 with Biofarma for the phytopharmaceutical Mexican market
Read the ITALIAN version
Ready-to-deliver machines and local sales network: the keys to the success of this cooperation
Biofarma Natural CMD, S.A. de C.V., a pharmaceutical company based in Mexico decided to entrust MG2 to optimize the management of a new manufacturing line dedicated to phytopharmaceutical products.
The Mexican company was looking for an off-the-shelf solution to strengthen its production capacity in short time by switching to high-speed automatic production, to satisfy the requirements of a growing market.
Suprema, continuous-motion capsule filler developed for medium productions up to 48.000 capsules/hour allows to dose powders and pellets with a high level of accuracy.
These features, together with an extremely competitive price, make Suprema an ideal entry-level model for companies looking for a simple machine, without any weight control system, cheap but efficient and reliable.
The usability of MG2 machines also applies to the installation procedures. Due to the pandemic emergency, Biofarma’s machine was installed by performing a remote SAT, a customer care procedure which is now well consolidated at MG2.
An essential role was played by the local agent, Mr. Eduardo Dominguez, Director of OPUS-Asesores, who takes care of the Mexican market by supporting and strengthening MG2 position; Eduardo assisted the customer on-site during the installation phases, and he actively cooperated to make the SAT successful, with the help of MG2 technicians, located in Pianoro, where a native speaking Spanish engineer was following the good execution of each step of the required procedures.
Supporting the customer
The Latin American market in general and Mexican in particular, is characterized by a strong dynamism and it is oriented to the purchase of ready-to-deliver machines.
This is the case of Biofarma, a project that has been accomplished in record time: one month elapsed from the starting offer enquiry and the remote FAT.
This first satisfying experience with the MG2 technology and the constant growth of the Mexican company, led Biofarma to further expand its production lines with the purchase of a new MG Compact capsule filler, for which the FAT was executed in the Summer 2021.